M. D. M. Álvarez-Torres

发表

Vascular differences between glioblastoma IDH-wildtype and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic level

F. García-García, E. Fuster-García, J. García-Gómez, 2022, medRxiv.

Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study

Carlos Sáez, Luaba Tshibanda, Girolamo Crisi, 2020, Journal of magnetic resonance imaging : JMRI.

Differential effect of vascularity between long‐ and short‐term survivors with IDH1/2 wild‐type glioblastoma

À. Rovira, S. Filice, J. M. García-Gómez, 2021, NMR in biomedicine.

High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics

K. Schmainda, E. Warnert, F. Riemer, 2022, Frontiers in Oncology.

MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas

À. Rovira, P. Due-Tønnessen, S. Filice, 2020, European Radiology.

Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT

C. Balañà, J. M. García-Gómez, J. Puig, 2021, Cancers.

Lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastoma: a confirmatory study.

C. Balañà, J. M. García-Gómez, E. Fuster-García, 2021, medRxiv.

ONCOhabitats Glioma Segmentation Model

Elies Fuster-García, Juan M. García-Gómez, Javier Juan-Albarracín, 2019, BrainLes@MICCAI.

Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification

J. M. García-Gómez, J. Ferrer-Lozano, J. Juan-Albarracín, 2022, BMC Cancer.

Vascular differences between IDH‐wildtype glioblastoma and astrocytoma IDH‐mutant grade 4 at imaging and transcriptomic levels

J. M. García-Gómez, E. Fuster-García, Francisco García-García, 2023, NMR in biomedicine.

Detection of local microvascular proliferation in IDH wild-type Glioblastoma using relative Cerebral Blood Volume.

J. M. García-Gómez, J. Ferrer-Lozano, J. Juan-Albarracín, 2021, medRxiv.

Unlocking Bevacizumab’s Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients

C. Balañà, J. M. García-Gómez, E. Fuster-García, 2023, Cancers.

The prognostic relevance of a gene expression signature in MRI-defined highly vascularized glioblastoma

J. M. García-Gómez, E. Fuster-García, M. D. M. Álvarez-Torres, 2024, Heliyon.